Study to Evaluate the Effects of Hepatic Impairment on the Pharmacokinetics of Miricorilant

Clinical trial NCT05553470 · COMPLETED

Trial details

NCT number: NCT05553470
Sponsor: Corcept Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Non-alcoholic Steatohepatitis (NASH)

Start date: 2022-03-03
Primary completion: 2024-09-13
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.